Join
Live feed
·
INSIDERFilingvia Quantisnow
Beta Bionics Inc. logo

Chief Commercial Officer Hopman Mark was granted 35,000 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
BBNX· Beta Bionics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BBNX (Beta Bionics Inc.) and more on Quantisnow.